Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05550324 · ClinicalTrials.gov registry record
IPSC Repository of Pediatric Cardiovascular Disease
A clinical trial of Heart Diseases and Congenital Heart Disease, sponsored by Mingtao Zhao.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05550324 is a study of Heart Diseases and Congenital Heart Disease that is actively recruiting participants, run by Mingtao Zhao. The registered enrollment target is 300 participants, below the 5,529-participant average among 85 other Heart Diseases trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05550324, a study of Heart Diseases and Congenital Heart Disease, is actively recruiting participants, sponsored by Mingtao Zhao.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
Conditions Studied
Interventions
- PROCEDURE Blood draw
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05550324
The ClinicalTrials.gov registry entry for NCT05550324 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,529-participant average among 85 other Heart Diseases trials with a reported enrollment target (95% lower). The listed sponsor is Mingtao Zhao, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT05550324 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05550324 about?
NCT05550324 is a clinical study titled "IPSC Repository of Pediatric Cardiovascular Disease". Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
What is the current status of trial NCT05550324?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-07-02. Estimated completion is 2030-12-31.
What conditions does trial NCT05550324 study?
This clinical trial studies the following conditions: Heart Diseases, Congenital Heart Disease.
What interventions are being tested in trial NCT05550324?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT05550324?
This trial is sponsored by Mingtao Zhao, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05550324 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.